A propensity matched analysis of outcomes and long term survival in stented versus stentless valves. 2017

Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
Department of Thoracic and Cardiovascular Surgery, Spectrum Health, Fred and Lena Meijer Heart and Vascular Institute, 100 Michigan St NE, Grand Rapids, MI, 49503, USA. blake.shultz@yale.edu.

BACKGROUND To compare the perioperative and long term survival after aortic valve replacement using stentless versus stented valves in a large cohort of patients grouped using propensity score matching. METHODS From 1991 to 2012, 4,563 patients underwent aortic valve replacement with stentless and stented valves at our institution. Propensity score matching identified 444 pairs using 13 independent variables: incidence of operation, smoking status, renal failure, hypertension, diabetes, peripheral vascular disease, cerebrovascular disease, chronic lung disease, ejection fraction, gender, age, valve status, and use of coronary artery bypass graft. Data were collected from our Society of Thoracic Surgeons database and the Social Security Death Index. Groups were compared using univariate and Kaplan-Meier analysis. RESULTS The two groups demonstrated no significant differences for the 13 matching variables and the majority of 30-day outcomes (p > 0.05). The stented valve group showed a higher incidence of postoperative bleeding (3.6% vs 1.1%, p = 0.015), but a lower incidence of stroke (0.9% vs. 2.9%, p = 0.028). One, five, and 10-year survival was 95.0, 80.7, and 52.8% for stented and 93.2, 80.5, and 51.3% for stentless valves. Overall survival did not differ significantly between the two groups (p = 0.641). CONCLUSIONS Stentless and stented valves had identical 30-day outcomes except for a higher postoperative incidence of bleeding and a lower incidence of stroke in the stented group. There was no significant difference in long term survival between valve types. Both valves may be used for aortic valve replacement with low morbidity and excellent long term survival.

UI MeSH Term Description Entries
D008297 Male Males
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001021 Aortic Valve The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. Aortic Valves,Valve, Aortic,Valves, Aortic
D001024 Aortic Valve Stenosis A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA. Aortic Stenosis,Aortic Valve Stenoses,Stenoses, Aortic,Stenoses, Aortic Valve,Stenosis, Aortic,Stenosis, Aortic Valve,Valve Stenoses, Aortic,Valve Stenosis, Aortic
D001705 Bioprosthesis Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. Glutaraldehyde-Stabilized Grafts,Heterograft Bioprosthesis,Porcine Xenograft Bioprosthesis,Xenograft Bioprosthesis,Bioprostheses,Bioprostheses, Heterograft,Bioprostheses, Porcine Xenograft,Bioprostheses, Xenograft,Bioprosthesis, Heterograft,Bioprosthesis, Porcine Xenograft,Bioprosthesis, Xenograft,Glutaraldehyde Stabilized Grafts,Glutaraldehyde-Stabilized Graft,Graft, Glutaraldehyde-Stabilized,Grafts, Glutaraldehyde-Stabilized,Heterograft Bioprostheses,Porcine Xenograft Bioprostheses,Xenograft Bioprostheses,Xenograft Bioprostheses, Porcine,Xenograft Bioprosthesis, Porcine

Related Publications

Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
January 2020, Innovations (Philadelphia, Pa.),
Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
December 2017, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia,
Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
November 1997, Circulation,
Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
January 2022, Seminars in thoracic and cardiovascular surgery,
Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
May 2011, The Journal of heart valve disease,
Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
January 2008, Journal of cardiac surgery,
Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
July 2021, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
October 2001, Seminars in thoracic and cardiovascular surgery,
Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
August 2020, Brazilian journal of cardiovascular surgery,
Blake N Shultz, and Tomasz Timek, and Alan T Davis, and John Heiser, and Edward Murphy, and Charles Willekes, and Robert Hooker
August 2022, Korean circulation journal,
Copied contents to your clipboard!